Featured Videos |view more
MUSC surgeon Ramsay Camp, M.D., discusses HIPEC for patients with cancer within the peritoneum, which is hard to treat with intravenous chemotherapy.
Alexander Vandergrift, M.D., a neurosurgeon at MUSC, describes removing a nonfunctioning pituitary tumor from a patient through endonasal resection using an endoscope.
Although technically challenging, robotic abdominoperineal resection (APR) with robotic harvest of the rectus abdominus muscular flap can eliminate the need for a midline laparotomy, reduce wound infection rates and lead to faster recovery.
Featured Articles and Documents |view more
Finding cancer quickly is key in securing the best possible outcome for the patient. An MUSC research team has found a way to make a lethal type of liver cancer more easily detectable.
It’s a figure that stands out. Black women have a 36% higher breast cancer mortality rate than other races in spite of having a similar incidence to White women.
With about 350 new cases of medulloblastoma each year, this cancer is classified as a rare disease and doesn’t get as much attention as more common cancers. But to researcher Jezabel R. Blanco, Ph.D., that’s all the more reason to focus ...
Removing toxic chemotherapeutic drugs from blood after cancer treatment prevents them from reaching the heart
The Hollings Cancer Center at the Medical University of South Carolina is a National Cancer Institute-designated cancer center and the largest academic-based cancer research program in South Carolina. The cancer center comprises more than 120 faculty cancer scientists with an annual research funding portfolio of $44 million and a dedication to reducing the cancer burden in South Carolina. Hollings offers state-of-the-art diagnostic capabilities, therapies and surgical techniques within multidisciplinary clinics that include surgeons, medical oncologists, radiation therapists, radiologists, pathologists, psychologists and other specialists equipped for the full range of cancer care, including more than 200 clinical trials.